I/ITSEC 2017: US Army to acquire WIAMan
The US Army is set to invest in the new Warrior Injury Assessment Manikin (WIAMan) anthropomorphic test device (ATD) which is set to go into to production in 2018.
The main objective of the WIAMAN is to create a scientifically valid under-body blast (UBB) injury assessment capability when testing ground ...
Want to read more?
Premium news content is only available to Shephard Plus subscribers or Online News subscribers